retatrutide type 2 diabetes phase 2 results 2024 Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, 3 Retatrutide produces up to 30.3%

These include Alzheimers disease, Parkinsons disease and alcohol use disorder (Figure 2)

Specific supplement ingredients with some evidence If you still want to explore supplementation alongside lifestyle changes, the ingredients with the strongest (though still limited) evidence for supporting GLP-1 include berberine (500-1500 mg daily), green tea extract containing EGCG, and curcumin with piperine for enhanced absorption

Browse more Peptides & GLP-1 education

Clinical and patient-reported outcomes from patients with nonalcoholic fatty liver disease across the world: data from the global non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD) registry

Feeling Unsatisfied After Meals Protein contributes to meal satisfaction

A significant drop in milk production